SABCS15 Friday Press Conference
Moderator: SABCS Co-director Kent Osborne, MD, director of the Dan L Duncan Cancer Center at Baylor College of Medicine T-DM1 Improved Overall Survival for Heavily Pretreated Patients With HER2-positive Breast Cancer; Phase III BELLE-2 Trial Meets Primary Endpoint of Progression-free Survival; No Significant Difference in Recurrence Rates Among Women With DCIS Taking Anastrozole or Tamoxifen; and DCIS Patients Receiving Anastrozole Reported Symptoms Different From Those Receiving Tamoxifen.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of AACR Scientific Podcasts?
This episode is 1 hour and 7 minutes long.
When was this AACR Scientific Podcasts episode published?
This episode was published on December 11, 2015.
Can I download this AACR Scientific Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.